Cargando…
Nanocarrier-Based Drug Delivery for Melanoma Therapeutics
Melanoma, as a tumor cell derived from melanocyte transformation, has the characteristics of malignant proliferation, high metastasis, rapid recurrence, and a low survival rate. Traditional therapy has many shortcomings, including drug side effects and poor patient compliance, and so on. Therefore,...
Autores principales: | Song, Mingming, Liu, Chang, Chen, Siyu, Zhang, Wenxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918190/ https://www.ncbi.nlm.nih.gov/pubmed/33668591 http://dx.doi.org/10.3390/ijms22041873 |
Ejemplares similares
-
Targeted Delivery of Drugs and Genes Using Polymer Nanocarriers for Cancer Therapy
por: Xia, Wentao, et al.
Publicado: (2021) -
Self-assembled polymeric nanocarrier-mediated co-delivery of metformin and doxorubicin for melanoma therapy
por: Song, Mingming, et al.
Publicado: (2021) -
Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery
por: Lombardo, Domenico, et al.
Publicado: (2016) -
Hyaluronic Acid-Based Nanocarriers for Anticancer Drug Delivery
por: Fu, Chao-Ping, et al.
Publicado: (2023) -
Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System
por: Akhter, Md Habban, et al.
Publicado: (2022)